Introduction: The COVID-19 infection can have varied severity; presenting symptoms include fever, coughing, headaches, sore throats, exhaustion, muscle aches, loss of taste or smell, rhinorrhea, stomach pain, diarrhea, and vomiting. In various parts of the world, including India, researchers have looked into the relationship between blood type and the severity of SARS-CoV-2 infection. The aim of the study is to investigate the relationship between COVID-19 infection severity and blood group.
Methodology: A total of 1,222 COVID-19 patients with real-time reverse transcription-polymerase chain reaction (RT-PCR) confirmation of being COVID-positive were included in the study. Mortality rates, demographic information, comorbid illnesses, epidemiological information, laboratory test results, and comorbid disorders were all retrieved. Each participant's RH type and Groups A, B, O, and AB were determined. IBM SPSS software version 26 (IBM Corp., Armonk, NY) was used for the statistical analysis. For a normal distribution, quantitative variables were shown as mean standard deviation (SD), and for a non-normal distribution, median (interquartile range (IQR)). Frequency and percentages were used to present qualitative characteristics.
Results: Out of the 1,222 patients included in the study, 369 were normal, 406 were mild, 317 were moderate, and 130 were severe based on COVID-19 CT severity scoring. Among the blood groups, O positive (+) was the most common with 503 (41.2%) study participants, and AB negative (-) was the least common with seven (0.6%) participants.
Discussion: In our study, comparing various blood groups, blood group O individuals have the highest risk of developing severe COVID-19 illness, and blood group AB individuals have a reduced risk. In terms of Rh status, patients who are Rh-positive are at increased risk of developing severe COVID-19 infection when compared with Rh- individuals. In the Indian population, blood group O is the commonest, and blood group AB is the least prevalent. Most of the individuals were Rh+, and the rest were Rh-. This is attributed to the increased infection rate in individuals with O+ blood type seen in our study when compared with other studies.
Conclusion: The findings indicated that individuals with blood groups A, B, and AB may be at a higher risk of severe COVID-19 infection, while blood group O might provide some protective effect. These results align with previous studies worldwide, suggesting that blood groups could influence the susceptibility to and severity of viral infections. The study emphasizes the need for further research with larger sample sizes and diverse populations to validate these findings and explore the underlying mechanisms.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624934 | PMC |
http://dx.doi.org/10.7759/cureus.46506 | DOI Listing |
Braz J Otorhinolaryngol
January 2025
Ankara Yıldırım Beyazıt University Faculty of Medicine, Department of Otorhinolaryngology, Ankara, Turkey.
Objectives: The aim of this study was to investigate the risk factors that may cause postoperative otomycosis in patients undergoing Chronic Nonsuppurative Otitis Media (CNSOM) surgery.
Methods: In this retrospective study, 409 out of 523 patients met the inclusion criteria. 44 patients diagnosed with otomycosis CNSOM were analyzed.
ARP Rheumatol
January 2024
Instituto de Medicina Molecular-João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Portugal.
Introduction - Rheumatoid arthritis (RA) is a chronic immune-mediated inflammatory disease, which causes local and systemic bone damage. The main goal of this work was to analyze, how treatment intervention with Ab501 (certolizumab mice equivalent) prevents the disturbances on bone structure and mechanics induced by arthritis. Methods - Thirty DBA/1 collagen-induced arthritis (CIA) mice were randomly housed in experimental groups, as follows: arthritic untreated (N=9), preventive intervention (N=10) and treatment intervention (N=11).
View Article and Find Full Text PDFVet Rec
January 2025
Department of Obstetrics and Gynaecology, Faculty of Veterinary Medicine, Harran University, Sanliurfa, Turkey.
Background: This study aimed to evaluate the effects of administering flunixin meglumine (FM) and meloxicam (M) on specific days post-mating on progesterone (P4), total oxidant status (TOS), total antioxidant status (TAS), oxidative stress index (OSI), pregnancy-specific protein B (PSPB), pregnancy-associated glycoprotein (PAG) concentrations and fertility parameters in Awassi sheep.
Methods: Seventy-five Awassi sheep were divided into three groups of 25: control, M and FM. On days 9 and 10 post-mating, the control group received saline, the M group received 0.
Cancer Commun (Lond)
January 2025
Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Centre, Shanghai, P. R. China.
Background: Hormone receptor-positive (HR+)/humaal growth factor receptor 2-negative (HER2-) breast cancer, the most common breast cancer type, has variable prognosis and high recurrence risk. Neoadjuvant therapy is recommended for median-high risk HR+/HER2- patients. This phase II, single-arm, prospective study aimed to explore appropriate neoadjuvant treatment strategies for HR+/HER2- breast cancer patients.
View Article and Find Full Text PDFJ Sports Sci
January 2025
Applied Sport, Technology, Exercise and Medicine Research Centre, Swansea University, Wales, UK.
We investigated the effects of low and high frequency isometric handgrip exercise training (IHGT) on resting blood pressure, and the affective/perceptual responses during training. Sixty young normotensive adults were randomised to either a no-intervention control group (CON: = 20; 12 female) or a group performing either two (LOW: = 20; 18 female) or four (HIGH: = 20; 13 female) sessions/week of IHGT for 4 weeks. IHGT involved 4 × 2-min holds at 30% maximal voluntary contraction using the dominant hand.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!